Widespread alterations in the peripheral blood innate immune cell profile in cystic fibrosis reflect lung pathology.


Journal

Immunology and cell biology
ISSN: 1440-1711
Titre abrégé: Immunol Cell Biol
Pays: United States
ID NLM: 8706300

Informations de publication

Date de publication:
04 2019
Historique:
received: 22 12 2017
revised: 30 07 2018
revised: 08 12 2018
accepted: 09 12 2018
pubmed: 12 1 2019
medline: 25 1 2020
entrez: 12 1 2019
Statut: ppublish

Résumé

Cystic fibrosis (CF) is caused by mutations to the CF transmembrane conductance regulator (CFTR) gene. CFTR is known to be expressed on multiple immune cell subtypes, dendritic cells, monocytes/macrophages, neutrophils and lymphocytes. We hypothesized that the lack of CFTR expression on peripheral blood innate immune cells would result in an altered cell profile in the periphery and that this profile would reflect lung pathology. We performed a flow cytometric phenotypic investigation of innate immune cell proportions in peripheral blood collected from 17 CF patients and 15 age-matched healthy controls. We observed significant differences between CF patients and controls in the relative proportions of natural killer (NK) cells, monocytes and their subsets, with significant correlations observed between proportions of NK and monocyte cell subsets and lung function (forced expiratory volume in 1 sec, % predicted; FEV1% predicted) in CF patients. This study demonstrates the widespread nature of immune dysregulation in CF and provides a basis for identification of potential therapeutic targets. Modulation of the distinct CF-related immune cell phenotype identified could also be an important biomarker for evaluating CFTR-targeted drug efficacy.

Identifiants

pubmed: 30633378
doi: 10.1111/imcb.12230
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-426

Informations de copyright

© 2019 Australasian Society for Immunology Inc.

Auteurs

Emily M Mulcahy (EM)

School of Medicine, University of Tasmania, Hobart, TAS, Australia.
Royal Hobart Hospital, Hobart, TAS, Australia.

Margaret A Cooley (MA)

School of Medicine, University of Tasmania, Hobart, TAS, Australia.

Helen McGuire (H)

Centenary Institute, Newtown, NSW, Australia.
Discipline of Pathology, University of Sydney, Sydney, NSW, Australia.

Suzanne Asad (S)

Centenary Institute, Newtown, NSW, Australia.

Barbara Fazekas de St Groth (B)

Centenary Institute, Newtown, NSW, Australia.
Discipline of Pathology, University of Sydney, Sydney, NSW, Australia.

Sean A Beggs (SA)

School of Medicine, University of Tasmania, Hobart, TAS, Australia.
Royal Hobart Hospital, Hobart, TAS, Australia.

Louise F Roddam (LF)

School of Medicine, University of Tasmania, Hobart, TAS, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH